Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Capricor Therapeutics (CAPR) over the last 9 years, with Sep 2025 value amounting to $4.6 million.

  • Capricor Therapeutics' Accumulated Depreciation & Amortization rose 43.46% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year increase of 46.78%. This contributed to the annual value of $3.5 million for FY2024, which is 56.39% up from last year.
  • Latest data reveals that Capricor Therapeutics reported Accumulated Depreciation & Amortization of $4.6 million as of Q3 2025, which was up 11.79% from $4.2 million recorded in Q2 2025.
  • Capricor Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $4.6 million during Q3 2025, with a 5-year trough of $756,712 in Q4 2021.
  • For the 3-year period, Capricor Therapeutics' Accumulated Depreciation & Amortization averaged around $2.9 million, with its median value being $2.9 million (2024).
  • Data for Capricor Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY surged of 86.70% (in 2023) over the last 5 years.
  • Over the past 5 years, Capricor Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $756,712 in 2021, then spiked by 56.15% to $1.2 million in 2022, then spiked by 86.70% to $2.2 million in 2023, then surged by 56.39% to $3.5 million in 2024, then soared by 43.46% to $4.6 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $4.6 million for Q3 2025, versus $4.2 million for Q2 2025 and $3.7 million for Q1 2025.